Your browser doesn't support javascript.
loading
EGFR V834L and L858R Comutation Is Associated With Response to Osimertinib in Non-Small-Cell Lung Cancer.
Giustini, Nicholas P; Pritchard, Colin C; Kamat, Nikhil V; Menon, Manoj P.
Afiliação
  • Giustini NP; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • Pritchard CC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
  • Kamat NV; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.
  • Menon MP; Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA.
JCO Precis Oncol ; 8: e2300215, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38991179
ABSTRACT
Up-front osimertinib leads to clinical benefit in EGFR V834L and L858R comutated NSCLC.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Compostos de Anilina / Neoplasias Pulmonares Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB / Compostos de Anilina / Neoplasias Pulmonares Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JCO Precis Oncol Ano de publicação: 2024 Tipo de documento: Article